148 related articles for article (PubMed ID: 32943104)
1. Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Toya Y; Akasaka R; Matsumoto T; Sugai T
Diagn Pathol; 2020 Sep; 15(1):111. PubMed ID: 32943104
[TBL] [Abstract][Full Text] [Related]
2. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas.
Sugai T; Habano W; Uesugi N; Jao YF; Nakamura S; Abe K; Takagane A; Terashima M
Mod Pathol; 2004 Oct; 17(10):1223-34. PubMed ID: 15154009
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression profile of key molecules in crawling-type early gastric carcinoma.
Woo HY; Bae YS; Kim JH; Lee SK; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2017 Jul; 20(4):612-619. PubMed ID: 27734272
[TBL] [Abstract][Full Text] [Related]
4. Serrated adenoma of the stomach: a clinicopathologic, immunohistochemical, and molecular study of nine cases.
Kwon MJ; Min BH; Lee SM; Park HY; Kang SY; Ha SY; Lee JH; Kim JJ; Park CK; Kim KM
Histol Histopathol; 2013 Apr; 28(4):453-62. PubMed ID: 23404616
[TBL] [Abstract][Full Text] [Related]
5. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
[TBL] [Abstract][Full Text] [Related]
7. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and molecular features of sporadic gastric foveolar type neoplasia.
Sugai T; Uesugi N; Habano W; Sugimoto R; Eizuka M; Fujita Y; Osakabe M; Toya Y; Suzuki H; Matsumoto T
Virchows Arch; 2020 Dec; 477(6):835-844. PubMed ID: 32533343
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract][Full Text] [Related]
10. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
Tajima Y; Yamazaki K; Makino R; Nishino N; Masuda Y; Aoki S; Kato M; Morohara K; Kusano M
Br J Cancer; 2007 Feb; 96(4):631-8. PubMed ID: 17262083
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers.
Sugai T; Habano W; Endoh M; Konishi Y; Akasaka R; Toyota M; Yamano H; Koeda K; Wakabayashi G; Suzuki K
Int J Cancer; 2010 Dec; 127(11):2500-9. PubMed ID: 20178104
[TBL] [Abstract][Full Text] [Related]
12. A gastric invasive tubular adenocarcinomatous lesion arising from foveolar-type neoplasia: molecular histogenesis.
Sugai T; Uesugi N; Hamada K; Nagahashi T; Horikawa Y; Suzuki M; Sugimoto R; Yanagawa N
Clin J Gastroenterol; 2024 Apr; ():. PubMed ID: 38662253
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma.
Uesugi N; Sugai T; Sugimoto R; Eizuka M; Fujita Y; Sato A; Osakabe M; Ishida K; Koeda K; Sasaki A; Matsumoto T
Pathology; 2017 Oct; 49(6):596-603. PubMed ID: 28830689
[TBL] [Abstract][Full Text] [Related]
14. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
15. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Molecular Findings of Differentiated-Type Minute Gastric Intramucosal Neoplasia.
Uesugi N; Sugai T; Sugimoto R; Eizuka M; Fujita Y; Sato A; Osakabe M; Ishida K; Shiomi E; Toya Y; Akasaka R; Matsumoto T
Digestion; 2020; 101(3):287-297. PubMed ID: 30943518
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in gastric cancer is closely associated with hMLH1 hypermethylation at the proximal region of the promoter.
Ishiguro K; Kawakami K; Maeda K; Ishida Y; Omura K; Watanabe G
Int J Mol Med; 2003 Oct; 12(4):603-8. PubMed ID: 12964042
[TBL] [Abstract][Full Text] [Related]
18. A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).
Matsuda I; Kan K; Doi S; Motoki Y; Onodera M; Hirota S
Int J Clin Exp Pathol; 2015; 8(9):11766-71. PubMed ID: 26617924
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa.
Guo RJ; Arai H; Kitayama Y; Igarashi H; Hemmi H; Arai T; Hanai H; Sugimura H
Pathol Int; 2001 Apr; 51(4):240-7. PubMed ID: 11350605
[TBL] [Abstract][Full Text] [Related]
20. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
